AKBA - Akebia Therapeutics, Inc.

Name: Akebia Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Classified under Pharmaceuticals (Health Care sector), AKBA's insider flows are most useful compared with peers in the same group.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Butler John P.	3.72M	$2.34M	-
VP	Burke Steven Keith	948.4K	$1.32M	-
CFO	Ostrowski Erik	616.6K	$684.4K	-
VP	Rucci Carolyn M.	588.4K	$817.8K	-
Other	Grund Nicholas	561.8K	$780.8K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 25, 2023	Hadas Nicole R.60	SVP, Chief Legal Officer	Sell	63,186	$1.22	$77,270.16	-10.8%	+6.6%	-9.1%
May 25, 2023	Dahan Michel59	SVP, Chief Operating Officer	Sell	95,478	$1.22	$116,760.05	-14.3%	+6.6%	-9.1%
May 16, 2023	Burke Steven Keith61	SVP, Chief Medical Officer	Sell	63,567	$1.07	$67,889.56	-10.7%	+25.7%	+12.4%
May 16, 2023	Spellman David A52	SVP, CFO and Treasurer	Sell	63,567	$1.07	$67,889.56	-12.5%	+25.7%	+12.4%
Mar 1, 2023	Dahan Michel59	SVP, Chief Operating Officer	Sell	20,412	$0.88	$17,911.53	-7.0%	+4.8%	+72.7%
Mar 1, 2023	Burke Steven Keith61	SVP, Chief Medical Officer	Sell	14,123	$0.88	$12,392.93	-2.3%	+4.8%	+72.7%
Mar 1, 2023	Hadas Nicole R.60	SVP, Chief Legal Officer	Sell	13,034	$0.88	$11,437.33	-4.3%	+4.8%	+72.7%
Mar 1, 2023	Butler John P.61	CEO and President	Sell	91,868	$0.88	$80,614.17	-5.5%	+4.8%	+72.7%
Mar 1, 2023	Spellman David A52	SVP, CFO and Treasurer	Sell	7,210	$0.88	$6,326.78	-1.4%	+4.8%	+72.7%
Feb 27, 2023	Butler John P.61	CEO and President	Sell	38,632	$0.81	$31,415.54	-2.3%	+17.5%	+101.1%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC